An Automated, Online Feasibility Randomized Controlled Trial of a Just-In-Time Adaptive Intervention for Smoking Cessation (Quit Sense)
Nicotine and Tobacco Research · 09.06.2023 · 25 (7) · 1319-1329
DOI: 10.1093/ntr/ntad032 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nicotine and Tobacco Research, online erschienen am 14.04.2023. Verfasst von Felix Naughton und 13 weiteren Autor:innen. Beteiligte Einrichtung: Behavioural and Implementation Science Group, School of Health Sciences, University of East Anglia, Norwich, UK. Hauptthemen laut MEDLINE: Smoking Cessation, Mobile Applications. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIHR, Public Health Research Programme, Department of Health and Social Care.
Abstract (Originalsprache)
Introduction
Learned smoking cues from a smoker’s environment are a major cause of lapse and relapse. Quit Sense, a theory-guided Just-In-Time Adaptive Intervention smartphone app, aims to help smokers learn about their situational smoking cues and provide in-the-moment support to help manage these when quitting.
Methods
A two-arm feasibility randomized controlled trial (N = 209) to estimate parameters to inform a definitive evaluation. Smoker’s willing to make a quit attempt were recruited using online paid-for adverts and randomized to “usual care” (text message referral to NHS SmokeFree website) or “usual care” plus a text message invitation to install Quit Sense. Procedures, excluding manual follow-up for nonresponders, were automated. Follow-up at 6 weeks and 6 months included feasibility, intervention engagement, smoking-related, and economic outcomes. Abstinence was verified using cotinine assessment from posted saliva samples.
Results
Self-reported smoking outcome completion rates at 6 months were 77% (95% CI 71%, 82%), viable saliva sample return rate was 39% (95% CI 24%, 54%), and health economic data 70% (95% CI 64%, 77%). Among Quit Sense participants, 75% (95% CI 67%, 83%) installed the app and set a quit date and, of those, 51% engaged for more than one week. The 6-month biochemically verified sustained abstinence rate (anticipated primary outcome for definitive trial), was 11.5% (12/104) among Quit Sense participants and 2.9% (3/105) for usual care (adjusted odds ratio = 4.57, 95% CIs 1.23, 16.94). No evidence of between-group differences in hypothesized mechanisms of action was found.
Conclusions
Evaluation feasibility was demonstrated alongside evidence supporting the effectiveness potential of Quit Sense.
Implications
Running a primarily automated trial to initially evaluate Quit Sense was feasible, resulting in modest recruitment costs and researcher time, and high trial engagement. When invited, as part of trial participation, to install a smoking cessation app, most participants are likely to do so, and, for those using Quit Sense, an estimated one-half will engage with it for more than 1 week. Evidence that Quit Sense may increase verified abstinence at 6-month follow-up, relative to usual care, was generated, although low saliva return rates to verify smoking status contributed to considerable imprecision in the effect size estimate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Behavioural and Implementation Science Group, School of Health Sciences, University of East Anglia, Norwich, UK.
- Addiction Research Group, Norwich Medical School, University of East Anglia, Norwich, UK.
- Department of Computer Science and Technology, University of Cambridge, Cambridge, UK.
- Norwich Clinical Trials Unit, University of East Anglia, Norwich, UK.
- Centre for Academic Primary Care, University of Nottingham, Nottingham, UK.
- Behavioural Science Group, University of Cambridge, Cambridge, UK.
ORCID-Profile: Felix Naughton, Caitlin Notley, Tim Coleman
Förderung
- NIHR
- Public Health Research Programme
- Department of Health and Social Care
Zitieren
APA
Naughton, F., Hope, A., Siegele-Brown, C., Grant, K., Barton, G., Notley, C., Mascolo, C., Coleman, T., Shepstone, L., Sutton, S., Prevost, A. T., Crane, D., Greaves, F., & High, J. (2023). An Automated, Online Feasibility Randomized Controlled Trial of a Just-In-Time Adaptive Intervention for Smoking Cessation (Quit Sense). Nicotine and Tobacco Research, 25(7), 1319-1329. https://doi.org/10.1093/ntr/ntad032
Vancouver
Naughton F, Hope A, Siegele-Brown C, Grant K, Barton G, Notley C, et al. An Automated, Online Feasibility Randomized Controlled Trial of a Just-In-Time Adaptive Intervention for Smoking Cessation (Quit Sense). Nicotine and Tobacco Research. 2023;25(7):1319-1329. doi:10.1093/ntr/ntad032
BibTeX
@article{Naughton2023,
author = {Naughton, Felix and Hope, Aimie and Siegele-Brown, Chloë and Grant, Kelly and Barton, Garry and Notley, Caitlin and Mascolo, Cecilia and Coleman, Tim and Shepstone, Lee and Sutton, Stephen and Prevost, A Toby and Crane, David and Greaves, Felix and High, Juliet},
title = {An Automated, Online Feasibility Randomized Controlled Trial of a Just-In-Time Adaptive Intervention for Smoking Cessation (Quit Sense)},
journal = {Nicotine and Tobacco Research},
year = {2023},
volume = {25},
number = {7},
pages = {1319--1329},
doi = {10.1093/ntr/ntad032}
}
EUVIMED